2023年4月21日

Caristo診斷有限公司——全球領先的心髒和血管疾病診斷和風險預測-進一步宣布,它已獲得£1300萬(1630萬美元)來總結其首輪融資。資金是由牛津大學科學企業和整編,長壁Venture Partners,牛津投資顧問LLP),牛津大學和其他投資者。心血管疾病(心血管病)被稱為全球死亡的首要原因,每年估計近1800萬人的生命。和Caristo旨在改變這統計通過交付其先進的冠狀動脈疾病的診斷技術。CaRi-Heart AI算法允許訓練有素的衛生專業人員獲取冠狀動脈炎症指標從常規心髒電腦斷層血管造影(CCTA)掃描通過Caristo脂肪衰減指數(FAI)技術。和由此產生的FAI分數措施由於冠狀動脈炎症心髒疾病而死亡的風險。+ CaRi-Heart提供了一個長期的心髒死亡風險通過整合冠狀動脈炎症與標準臨床危險因素與冠狀動脈斑塊的存在。資金將用於:Caristo將使用資本推動其CaRi-Heart技術、AI-assisted診斷,心髒保健和風險預測工具,標準在全球主要市場。關鍵引用:“我們感到欣慰的是,五個成功的機構投資者參與融資輪驗證Caristo大量臨床和商業潛力的創新。我們是同樣的興奮地歡迎弗蘭克程Caristo的新CEO。 Frank led multiple digital health companies during the last twenty years, and most recently was President & CCO of Eyenuk, Inc, a diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted in eighteen countries. With a portfolio of novel technologies, exceptional clinical results and an experienced management team, Caristo is well positioned to transform healthcare around the world.” – Oran Muduroglu, Board Chairman of Caristo “We invest in companies with the potential to revolutionize healthcare and become global category leaders and that is why we are proud to back the incredible team at Caristo. Caristo continues to make tremendous progress in the delivery of its innovative technology to help healthcare professionals predict and prevent future heart attacks and ultimately save millions of lives around the world. We are thrilled to continue being part of the company’s journey.” – Heather Roxborough, Head of HealthTech at Oxford Science Enterprises and Caristo Board Member “Caristo has been on an exciting journey since 2018 as the Company turned a scientific idea into a validated clinical offering, protected our intellectual property, published impressive results in leading peer-reviewed medical journals, and secured initial regulatory approvals. Our Series A fundraise will accelerate Caristo’s growth in our existing UK and EU markets, while we lay solid foundations for U.S. market entry.” – Frank Cheng, Caristo CEO and Board Member Trending on Pulse 2.0